EUVIMEDEUVIMED entdecken
Open Access

Low antiviral uptake of nirmatrelvir/ritonavir and molnupiravir in adult patients with COVID-19 in Taiwan in 2022

Fu-Der Wang, Phung-Anh Nguyen, David Lee, Bulent Taysi, Florence Lefebvre d'Hellencourt, Julia Spinardi, Phan Thanh Phuc, Whitney Burton, Yu-Hui Chang, Nguyen Thi Kim Hien, Shiue-Ming Lin, Yang Chieh und 2 weitere

Journal of Global Health · 2024

DOI: 10.7189/jogh.14.05032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Global Health, 2024. Verfasst von Fu-Der Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Antiviral Agents, Ritonavir, COVID-19, Hydroxylamines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsRitonavirCOVID-19HydroxylaminesCOVID-19 Drug TreatmentSARS-CoV-2HumansMaleFemaleMiddle AgedTaiwanAdultRetrospective StudiesAgedLeucinePandemicsProlinePyrrolidinesSulfonamidesOrganometallic CompoundsCytidineLactamsNitriles

Substanzen

Antiviral AgentsRitonavirmolnupiravirHydroxylaminesnirmatrelvirLeucineProlinePyrrolidinesSulfonamidesOrganometallic Compounds

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
  • National Yang-Ming Chiao-Tung University, Taipei, Taiwan.
  • Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, Taiwan.
  • Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan.
  • Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.
  • Research Center of Health Care Industry Data Science, College of Management, Taipei Medical University, Taipei, Taiwan.

Zitieren

APA

Wang, F. D., Nguyen, P. A., Lee, D., Taysi, B., Lefebvre d'Hellencourt, F., Spinardi, J., Phuc, P. T., Burton, W., Chang, Y. H., Hien, N. T. K., Lin, S. M., Chieh, Y., Kyaw, M. H., & Hsu, J. C. (2024). Low antiviral uptake of nirmatrelvir/ritonavir and molnupiravir in adult patients with COVID-19 in Taiwan in 2022. Journal of Global Health. https://doi.org/10.7189/jogh.14.05032

Vancouver

Wang FD, Nguyen PA, Lee D, Taysi B, Lefebvre d'Hellencourt F, Spinardi J, et al. Low antiviral uptake of nirmatrelvir/ritonavir and molnupiravir in adult patients with COVID-19 in Taiwan in 2022. Journal of Global Health. 2024. doi:10.7189/jogh.14.05032

BibTeX
@article{Wang2024,
  author = {Wang, Fu-Der and Nguyen, Phung-Anh and Lee, David and Taysi, Bulent and Lefebvre d'Hellencourt, Florence and Spinardi, Julia and Phuc, Phan Thanh and Burton, Whitney and Chang, Yu-Hui and Hien, Nguyen Thi Kim and Lin, Shiue-Ming and Chieh, Yang and Kyaw, Moe H and Hsu, Jason C},
  title = {Low antiviral uptake of nirmatrelvir/ritonavir and molnupiravir in adult patients with COVID-19 in Taiwan in 2022},
  journal = {Journal of Global Health},
  year = {2024},
  doi = {10.7189/jogh.14.05032}
}
Kostenlos starten →